In pursuance of the LODR with Stock Exchange, Bharat Immunological And Biological Corporation has informed that it enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2021 approved by the Board of the Company in its Meeting on 29.10.2021.
The above information is a part of company’s filings submitted to BSE.